Patents Assigned to Institut Virion \ Serion GmbH
  • Patent number: 11780884
    Abstract: The Rubella Virus Spike construct comprises at least one E1 component and one E2 component, which are linked together. The E1 component consists of the El envelope protein, whose C-terminal transmembrane region and intravirional domain are removed and whose N-terminus comprises the ectodomain of the El envelope protein. The E2 component consists of the E2 envelope protein whose transmembrane regions and intravirional domain removed and whose C-terminus comprising the ectodomain of the E2 envelope protein. The C-terminus of the E2 component is connected to the N-terminus of the E1 component by direct fusion or by means of a linker to form an E1-E2 fusion protein.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: October 10, 2023
    Assignees: Institut Virion \ Serion GmbH
    Inventors: Thomas Schumacher, Hugo Arends
  • Publication number: 20210261624
    Abstract: The Rubella Virus Spike construct comprises at least one E1 component and one E2 component, which are linked together. The E1 component consists of the E1 envelope protein, whose C-terminal transmembrane region and intravirional domain are removed and whose N-terminus comprises the ectodomain of the E1 envelope protein. The E2 component consists of the E2 envelope protein whose transmembrane regions and intravirional domain removed and whose C-terminus comprising the ectodomain of the E2 envelope protein. The C-terminus of the E2 component is connected to the N-terminus of the E1 component by direct fusion or by means of a linker to form an E1-E2 fusion protein.
    Type: Application
    Filed: February 14, 2020
    Publication date: August 26, 2021
    Applicants: Institut Virion \ Serion GmbH
    Inventors: Thomas SCHUMACHER, Hugo ARENDS